EDIT vs LYV · rev $32.3M vs P/E 49, rev $23.16B
Editas Medicine Inc (EDIT) versus Live Nation Entertainment Inc (LYV) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Live Nation Entertainment Inc (LYV) is a entertainment company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported LYV revenue for 2024-12-31 was $23.16B. Net income was $1.13B. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. LYV currently screens at market cap $33.36B and trailing P/E 48.8.
EDIT currently screens at market cap $375.2M. LYV currently screens at market cap $33.36B and trailing P/E 48.8.
Not investment advice. Open the EDIT and LYV stock pages for the full models.
Not investment advice.